Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Children's cancers, Hodgkin lymphoma, Lymphoma
Closed
Phase 2
This trial is looking at pembrolizumab after chemotherapy. It is open to children from 3 years old to young adults 25 years old who have classical Hodgkin lymphoma.
We use the term ‘you’ in the summary but if you are a parent we are referring to your child.
Recruitment start: 11 January 2021
Recruitment end: 21 September 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Stephen Daw
Merck Sharp & Dohme Ltd
Last reviewed: 01 Oct 2023
CRUK internal database number: 16883